alexa Bedside Molecular Diagnostics In The Clinical And Non-clinical Settings
ISSN: 2153-0645

Journal of Pharmacogenomics & Pharmacoproteomics
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

2nd International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics
November 03-05, 2014 Embassy Suites Las Vegas, USA

Adam Ruskin
Accepted Abstracts: J Pharmacogenomics Pharmacoproteomics
DOI: 10.4172/2153-0645.S1.004
Molecular diagnostic tools have been developed to be used outside of the traditional laboratory setting and in some cases for use while patients are waiting at the general practitioner?s office. These same tools have similar utility in environmental and food safety settings. As lead clinical developer for the industry?s smallest, most affordable and most sensitive molecular diagnostic platform, it was repeatedly demonstrated that the device could be placed within a routine clinical setting with accurate results generated while patients wait in order to administer appropriate therapy. Additionally, almost half of the requests for placement of the device came from environmental, food and water regulators as the device could identify DNA or RNA particles down to 50-60 live or dead base pairs in any liquefied medium in a completely hands-off methodology. As the source of the medium was irrelevant to the functioning of the diagnostic, particles could be detected in any type of water, animal or soil source. As development costs of these diagnostics continue to lower, placement of these devices throughout physicians offices and public health facilities should become the norm, changing the landscape of how physicians diagnose and treat patients for routine infectious diseases, and how outbreaks of diseases can be identified early on and prevented from becoming public health outbreaks.
Adam Ruskin completed his DVM from Kansas State University and PhD and MPH in Epidemiology from Emory University. After restructuring the CDC?s National Reportable Infectious Disease Surveillance System, he lead clinical development for over 80 pharmaceutical, medical device and diagnostic products over the past 20 years, including Gentura?sIDbox for molecular diagnostics. He has developed the industry?s first clinical trial laboratory tracking software and is a leading pharmaceutical and medical device industry best practices and keynote speaker. With 4 successful start-up companies, he now heads clinical development of LabCRO, one of the leading CROs for the diagnostics industry.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version